Table 3.
Analysis of factors significantly associated with gain over predicted adult height
| Gain Over Baseline Predicted Adult Heighta | |||
|---|---|---|---|
| Univariate Analysis | Correlation Coefficient | P-value | |
| At the start of therapy | |||
| CA (yr) | -0.43 | 0.0221 | |
| BA minus CA | 0.53 | 0.004 | |
| Time to treatment from onset of CPP (yr) | -0.39 | 0.0395 | |
| During therapy | |||
| Duration of the treatment | 0.52 | 0.0048 | |
| At the end of therapy | |||
| CA | 0.40 | 0.0369 | |
| Multiple Linear Regression | Beta Coefficient | P-value | R2 |
| BA-CA at baseline | 3.37 | 0.0028 | |
| Time to Treatment from onset of CPP (yr) | -3.84 | 0.0245 | 0.41 |
aAdult height minus predicted mature height at baseline